Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators (Q47635686)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 June 2009

Language	Label	Description	Also known as
English	Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators	scientific article published on 13 June 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

1 reference

based on heuristic

inferred from title

2

object named as

Johan Vijgen

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

author name string

Task force members

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Gianluca Botto

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

John Camm

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Carl-Johan Hoijer

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Werner Jung

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Jean-Yves Le Heuzey

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Andrzej Lubinski

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Tone M Norekvål

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Maurizio Santomauro

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Martin Schalij

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Jean-Paul Schmid

12

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Panos Vardas

13

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

publication date

13 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

1097-1107

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Driving and implantable cardioverter-defibrillators a clearer view.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Driving and arrhythmias: implications of new data

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Causes of impaired consciousness while driving a motorized vehicle

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Incidence and implications of natural deaths of road users

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

What are the current guidelines on the use of implantable defibrillators in transportation safety critical work?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of P

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Patients with implantable cardioverter-defibrillators and their conceptions of the life situation: a qualitative analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Motor vehicle accidents in patients with an implantable cardioverter-defibrillator.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Medical restrictions to driving: the awareness of patients and doctors

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Modification of patient driving behavior after implantation of a cardioverter defibrillator.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Resumption of driving after life-threatening ventricular tachyarrhythmia

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Syncope, driving recommendations, and clinical reality: survey of patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Sudden death behind the wheel from natural disease in drivers of four-wheeled motorized vehicles

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Low incidence of lead related complications associated with nonthoracotomy implantable cardioverter defibrillator systems.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Timing of delayed perforation with the St. Jude Riata lead: a single-center experience and a review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Performance of the St. Jude Medical Riata leads

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HR

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Prognostic importance of defibrillator shocks in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) tria

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Effect of exercise training in patients with an implantable cardioverter defibrillator.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUP112

21 January 2018

Identifiers

10.1093/EUROPACE/EUP112

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/19525498

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47635686&oldid=2163844469"